Separate NAD+, sermorelin and weight-care programmes

BeyondMD review

BeyondMD groups treatments around energy, recovery, weight and optimal aging. I would evaluate one clinical purpose at a time. The current NAD+ and weight listings establish real services, but the starting prices do not define their supplies, sermorelin has a price discrepancy, and the no-charge-if-declined language conflicts with the consultation-fee policy.

A useful next step?

Consider the purpose, the care relationship and the full commitment.

Visit BeyondMDOfficial provider website. No affiliate relationship is currently listed.

A reason to consider it

Readers prepared to assess a specific clinical service, actual preparation, monitoring plan and financial commitment independently of the broader wellness catalogue.

  • Current product pages identify NAD+, sermorelin and weight-care programmes.
  • The care process explains assessment, optional labs and ongoing contact.
  • The detailed policy distinguishes medical work, pharmacy processing and future cancellation.

What deserves scrutiny

Anyone expecting a single proven healthspan package, verified benefit from every listed peptide or a uniform all-inclusive monthly price.

  • The catalogue does not establish improved healthy lifespan from these services.
  • Exact preparations, supplied quantities and full monitoring bills need confirmation.
  • Sermorelin prices and medical-nonapproval charging language are inconsistent.
In this review

Select a clinical question before selecting a programme

BeyondMD’s current pages offer NAD+ injections, sermorelin injections and compounded weight-care programmes. The broader language about energy, recovery and optimal aging is not a controlled demonstration that the catalogue improves healthy lifespan. I would start with the problem being assessed and the outcome that would justify continuing, without assuming several listed therapies belong in one plan. [1] [2] [3] [4]

The public compounding disclosure acknowledges unapproved preparations, uncertain long-term effects and possible variation in strength, purity or stability. FDA does not approve compounded drugs before marketing. A claim about pharmaceutical-grade ingredients or a licensed pharmacy does not independently verify the actual product, dispenser license or batch. Obtain the preparation and assigned care details rather than inferring safety or benefit from those labels. [8] [9]

Price the chosen service rather than the whole catalogue

NAD+ injections start at $199. Sermorelin shows $179 at the offer heading and $219 in its expanded pricing FAQ. Compounded semaglutide starts at $125 and tirzepatide at $199. None of these starting figures defines a complete selected billing interval, formulation and supply. Resolve the sermorelin discrepancy and request the actual medication and service invoice. [1] [2] [3] [4]

The separate Wegovy consultation starts at $129 and describes medication coordination and optional insurance verification, without establishing an all-in drug price or coverage approval. Free membership describes provider access and programme support, not a prepaid package of every listed intervention. Keep optional tests, nutrition help and separate treatments distinct. [5] [10]

Make the monitoring and nonapproval agreement explicit

The care page describes reviewing health history and relevant labs, accepting existing results or arranging tests if needed, and maintaining provider contact. It does not establish a complete included panel or fixed monitoring schedule for every medicine. The semaglutide nutritionist option is not a universal dietitian-appointment benefit. State and individual eligibility remain relevant despite nationwide marketing. [3] [5] [7]

The same care page says treatment nonapproval means no charge; the detailed refund policy says consultation and clinical-review fees are not refundable after work starts even if no medication is appropriate. Ask for the selected programme’s written answer before assessment begins. This inconsistency matters independently of whether the clinical decision is reasonable. [5] [6]

Know when a future cancellation can still stop a charge

A medication cancellation is reviewed before pharmacy processing; processing or preparation usually ends refund eligibility, apart from appropriate remedies for attributable errors. Future programme cancellation does not reverse clinical services or an already processed order. Ask for the actual renewal and processing dates, because fulfillment can begin before the expected shipment date. No universal notice period or pro-rata refund is established. [6]

Wrong, damaged or missing medicine is investigated after prompt reporting and requested documentation; replacement, reshipment, credit or a refund may be appropriate. A late delivery or disappointing result alone is not an assured refund. The care page’s three-to-five-business-day assessment and later five-to-seven-day delivery estimates are separate, conditional stages. I would judge this service by a defined care relationship rather than the breadth of its optimal-aging menu. [5] [6]

Understanding the cost

NAD+ injection starts at $199; sermorelin heading $179 versus FAQ $219; compounded semaglutide $125/tirzepatide $199. These are not verified monthly supplies or one combined package. Wegovy consultation $129 is separate; confirm the actual service, medication, optional testing and support invoice.

Build your cost estimate

Sources

  1. BeyondMD: current NAD+ injection program
  2. BeyondMD: sermorelin listing and expanded price FAQ
  3. BeyondMD: compounded semaglutide program and optional support
  4. BeyondMD: compounded tirzepatide injection program
  5. BeyondMD: care process, laboratory and nonapproval answers
  6. BeyondMD: September 2 refund and cancellation policy
  7. BeyondMD: complete platform and clinical service terms
  8. BeyondMD: public compounded-product disclosure
  9. FDA: understanding the risks of compounded drugs
  10. BeyondMD: Wegovy consultation and expanded inclusions

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.